DK1827461T3 - CLADRIBIN REGULATION FOR TREATMENT OF MULTIPLE SCLEROSIS - Google Patents
CLADRIBIN REGULATION FOR TREATMENT OF MULTIPLE SCLEROSISInfo
- Publication number
- DK1827461T3 DK1827461T3 DK05823474.1T DK05823474T DK1827461T3 DK 1827461 T3 DK1827461 T3 DK 1827461T3 DK 05823474 T DK05823474 T DK 05823474T DK 1827461 T3 DK1827461 T3 DK 1827461T3
- Authority
- DK
- Denmark
- Prior art keywords
- multiple sclerosis
- treatment
- cladribin
- regulation
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Pressure Welding/Diffusion-Bonding (AREA)
Abstract
The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63866904P | 2004-12-22 | 2004-12-22 | |
EP04106909 | 2004-12-22 | ||
PCT/EP2005/056954 WO2006067141A1 (en) | 2004-12-22 | 2005-12-20 | Cladribine regimen for treating multiple sclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1827461T3 true DK1827461T3 (en) | 2012-03-26 |
Family
ID=34930135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05823474.1T DK1827461T3 (en) | 2004-12-22 | 2005-12-20 | CLADRIBIN REGULATION FOR TREATMENT OF MULTIPLE SCLEROSIS |
Country Status (10)
Country | Link |
---|---|
AT (1) | ATE547106T1 (en) |
DK (1) | DK1827461T3 (en) |
ES (4) | ES2382554T3 (en) |
HU (1) | HUE035859T2 (en) |
LT (1) | LT2805723T (en) |
ME (1) | ME01333B (en) |
PT (3) | PT3332789T (en) |
RS (1) | RS52219B (en) |
SI (1) | SI1827461T1 (en) |
UA (1) | UA96260C2 (en) |
-
2005
- 2005-12-20 PT PT181516345T patent/PT3332789T/en unknown
- 2005-12-20 PT PT140019704T patent/PT2805723T/en unknown
- 2005-12-20 ES ES05823474T patent/ES2382554T3/en active Active
- 2005-12-20 ME MEP-2012-35A patent/ME01333B/en unknown
- 2005-12-20 AT AT05823474T patent/ATE547106T1/en active
- 2005-12-20 PT PT05823474T patent/PT1827461E/en unknown
- 2005-12-20 SI SI200531514T patent/SI1827461T1/en unknown
- 2005-12-20 RS RS20120161A patent/RS52219B/en unknown
- 2005-12-20 ES ES10182676.6T patent/ES2495392T3/en active Active
- 2005-12-20 HU HUE14001970A patent/HUE035859T2/en unknown
- 2005-12-20 LT LTEP14001970.4T patent/LT2805723T/en unknown
- 2005-12-20 ES ES10182632T patent/ES2428741T3/en active Active
- 2005-12-20 ES ES14001970.4T patent/ES2666146T3/en active Active
- 2005-12-20 UA UAA200708371A patent/UA96260C2/en unknown
- 2005-12-20 DK DK05823474.1T patent/DK1827461T3/en active
Also Published As
Publication number | Publication date |
---|---|
SI1827461T1 (en) | 2012-05-31 |
PT1827461E (en) | 2012-05-07 |
ES2666146T3 (en) | 2018-05-03 |
ES2428741T3 (en) | 2013-11-11 |
ME01333B (en) | 2013-12-20 |
RS52219B (en) | 2012-10-31 |
PT3332789T (en) | 2022-07-05 |
UA96260C2 (en) | 2011-10-25 |
ATE547106T1 (en) | 2012-03-15 |
HUE035859T2 (en) | 2018-05-28 |
ES2495392T3 (en) | 2014-09-17 |
LT2805723T (en) | 2018-02-12 |
PT2805723T (en) | 2018-01-25 |
ES2382554T3 (en) | 2012-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201001669A1 (en) | SUBSTITUTED PYRIMIDIN-5-CARBOXAMIDES 281 | |
TW200722081A (en) | New therapeutic combinations for the treatment or prevention of depression | |
GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
TW200806300A (en) | New therapeutic combinations for the treatment of depression | |
WO2012007877A3 (en) | N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels | |
SG170069A1 (en) | Quinoline derivatives | |
GEP20156348B (en) | Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators | |
TW200616979A (en) | Non-nucleoside reverse transcriptase inhibitors | |
SG160391A1 (en) | Cladribine regimen for treating multiple sclerosis | |
PH12014501334A1 (en) | Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines | |
TW200833670A (en) | Novel compounds 569 | |
TW200745122A (en) | New compounds I | |
BRPI0407181A (en) | Pharmaceutical Formulation | |
DE60219005D1 (en) | SOLID PHARMACEUTICAL FORMULATION CONTAINING MODAFINIL | |
MA29278B1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING AN INDOLYLMALEIMIDE DERIVATIVE | |
TW200640465A (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
SE0303480D0 (en) | Benzofuranes | |
WO2007111983A8 (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
BRPI0618370A2 (en) | aerosol drug formulation, drug use and inhalation kit | |
TW200635592A (en) | Pyridyl-substituted spiro-hydantoin compounds and use thereof | |
WO2007099323A3 (en) | Quinoline derivatives | |
HK1107699A1 (en) | Ritonavir analogous compound useful as retroviral protease inhibitor, preparation of the ritonavir analogous compound and pharmaceutical composition for the ritonavir analogous compound | |
ATE496899T1 (en) | TETRAHYDRO- AND DIHYDROQUINAZOLINONES | |
DK1827461T3 (en) | CLADRIBIN REGULATION FOR TREATMENT OF MULTIPLE SCLEROSIS | |
CL2008002223A1 (en) | Compounds derived from 2'-o-substituted 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin; Preparation process; intermediate compound; pharmaceutical composition; and its use in the treatment and / or prophylaxis of malaria. |